[1] ZHANG Ruizhe LI Qian PEI Juan DANG Rong YANG Yuting WANG Chuan,.Overview of the Chemical Components and Pharmacological Effects of Eucommia Ulmoides [J]. Journal of Shaanxi University of Traditional Chinese Medicine, 2024, (04): 87-91. [doi: 10.13424/j.cnki.jsctcm.2024.04.017]
Overview of the Chemical Components and Pharmacological Effects of Eucommia Ulmoides
- Article number:
- 2096-1340(2024)04-0087-05
- Keywords:
- Key words： Eucommia ulmoides; Chemical composition; Pharmacological effects; Clinical application
- ZTFLH:
- R285.5
- Code:
- A
- Abstract:
- Abstract： Objective To summarize the research progress on the chemical components and pharmacological effects of Eucommia ulmoides in recent years，and provide a basis for its further development and utilization.Methods Using keywords such as “Eucommia ulmoides” “chemical components” “pharmacological effects” “European ulmoides” “chemical composition” and “pharmacological activity” relevant literature was searched in databases such as CNKI，Wanfang，VIP，PubMed，and Geenmedial.Summarize the research progress on the chemical composition，pharmacological effects，and clinical applications of Eucommia ulmoides based on existing literature.Results By searching relevant literature on CNKI and PubMed databases,the latest research achievements related to Eucommia ulmoides were summarized and summarized. This article reviews the chemical components of Eucommia ulmoides,including lignans,cycloene terpenes,flavonoids,phenylpropanoids,and other types of terpenes; Eucommia ulmoides has functions such as regulating blood sugar,blood lipids,blood pressure,anti osteoporosis,antiinflammatory,antioxidant,liver and kidney protection,immune regulation,antitumor,and anticancer.Conclusion Eucommia ulmoides contains chemical components such as lignans，iridoids，flavonoids，and phenylpropanoids;It has pharmacological effects such as lowering blood sugar，lowering blood lipids，antioxidation，and immune regulation;At present，it is mainly used to treat diabetes，hyperlipidemia，osteoporosis and other diseases.
References:
［1］何莉莎,刘莹莹,宋攀.重构本草——杜仲［J］.吉林中医药,2023,43(3):324-326.
［2］刘育婷,齐武强,滕薇,等.四种炮制方法对不同产地杜仲的指示性成分的影响分析［J］.陕西中医药大学学报,2020,43(1):76-79.
［3］胡杨,李先芝,刘洋,等.杜仲化学成分、药理作用及应用研究进展［J］.亚太传统医药,2022,18(2):234-239.
［4］高宏伟,李玉萍,李守超.杜仲的化学成分及药理作用研究进展［J］.中医药信息,2021,38(6):73-81.
［5］左月明,高凌云,张忠立.杜仲叶环氧木脂素类化学成分研究［J］.中药材,2022,45(9):2139-2143.
［6］张威鹏,朱雯,张良,等.杜仲主要活性成分含量及其与树龄和部位的相关性［J］.经济林研究,2020,38(3):46-57.
［7］黄文平,郭文静,吴永忠,等.杜仲不同药用部位及制剂中4种木脂素成分含量差异比较［J］.北京中医药,2020,39(5):504-507.
［8］WANG CY,TANG L,HE JW,et al.Ethnobotany,phytochemistry and pharmacological properties of Eucommia ulmoides:a review［J］.The American Journal of Chinese Medicine,2019,47(2):259-300.
［9］郭琴,高焕,李小锋,等.HPLC-MS/MS法同时测定杜仲饮片及其单方制剂中11种成分的含量［J］.中国药师,2022,25(2):369-372,385.
［10］朱琳,郝晓亮,徐园园,等.基于响应面优化杜仲多糖提取工艺的研究［J］.农业技术与装备,2022(5):64-66,69.
［11］王婷婷,贾娟,杨雯雯.杜仲黄酮类化合物提取方法研究进展［J］.中国果菜,2022,42(5):34-37.
［12］王婷婷,刘心如,贾娟,等.超声波辅助酶法提取杜仲叶中总黄酮的工艺优化［J］.饲料研究,2022,45(17):69-74.
［13］闫建昆,张翔宇,石旭柳,等.杜仲叶中黄酮类化学成分研究［J］.中国现代中药,2021,23(4):599-604.
［14］张子东,付冬梅,张威鹏,等.HPLC法同时测定不同生长年限不同部位杜仲中5种苯丙素类成分［J］.食品科学,2019,40(8):186-191.
［15］徐媛媛,骆骄阳,孙婷婷,等.杜仲药材国内外质量标准概述［J］.中国中药杂志,2021,46(14):3577-3582.
［16］刘巧,宗毅,相楚嫣,等.四种不同杜仲叶渣中绿原酸含量的比较［J］.中药与临床,2022,13(4):4-6.
［17］曹媛,吕玮坤,任耀龙,等.高血压病患者中医体质特点与心血管危险因素分析［J］.陕西中医药大学学报,2020,43(1):89-91.
［18］梅蛟,杨帆.杜仲治疗高血压研究进展［J］.世界最新医学信息文摘,2018,18(81):35-36.
［19］丁振江.杜仲花粉对高血压大鼠降压作用及机制研究［D］.开封:河南大学,2019.
［20］穆文碧,张建永,李明丹,等.杜仲黑茶中氨基酸和矿物元素分析及对“三高症”的影响［J］.遵义医科大学学报,2020,43(3):276-281.
［21］潘龙,支娟娟,许春国,等.杜仲糖苷对肾性高血压大鼠血压及血浆ET、NO的影响［J］.现代中医药,2010,30(2):54-56.
［22］郎茜,龚蕾,叶婧,等.杜仲叶多糖对糖尿病大鼠的降血糖作用［J］.现代食品科技,2020,36(10):27-32,78.
［23］邢冬杰,孙永显,陈桂玉,等.杜仲叶黄酮对糖尿病大鼠的血糖控制及对胰岛细胞的保护作用［J］.中国实验方剂学杂志,2015,21(13):148-151.
［24］雷燕妮,张小斌.杜仲叶总黄酮降血脂作用研究［J］.西北大学学报(自然科学版),2015,45(5):777-780,786.
［25］钟淑娟,杨欣,李静,等.杜仲不同部位总黄酮含量及抗氧化活性研究［J］.中国药房,2017,28(13):1787-1790.
［26］席晓志,王婉卿,崔晓伟,等.响应面优化杜仲提取物抗氧化活性及其工艺研究［J］.中国现代中药,2018,20(3):310-315.
［27］许激扬,陈勉,宋妍.杜仲不同活性部位对小鼠睡眠改善及免疫调节作用的研究［J］.上海中医药杂志,2006,40(11):63-65.
［28］辛晓明,王浩,冯蕾,等.杜仲总多糖对环磷酰胺致免疫低下小鼠的影响［J］.中国中医药信息杂志,2007,14(10):28-29.
［29］白璧辉.从“五劳所伤”探讨原发性骨质疏松症的发病机理［J］.现代中医药,2017,37(5):87-90.
［30］康照宁,徐林轩,蔡余力.单味中药治疗骨质疏松症的机理研究［J］.中医临床研究,2022,14(8):70-72.
［31］TAN XL,ZHANG YH,CAI JP,et al.5-(hydroxymethyl)-2-furaldehyde inhibits adipogenic and enhances osteogenic differentiation of rat bone mesenchymal stem cells［J］.Natural Product Communications,2014,9(4):1934578X1400900.
［32］赵亮,陈志明.盐炙杜仲对去卵巢骨质疏松大鼠骨代谢生化指标的影响［J］.时珍国医国药,2019,30(3):587-588.
［33］李宁博,骆晓飞,尹夏,等.杜仲多糖通过抑制NF-κB通路减轻IL-1β诱导的软骨细胞损伤［J］.中国骨伤,2022,35(7):661-668.
［34］周建辉.杜仲总黄酮体外抗乙肝病毒实验研究［J］.中医临床研究,2015,7(27):77-78.
［35］陈百泉,娄丽杰,杜红岩,等.杜仲雄花茶对小鼠镇静催眠作用的探讨［J］.河南大学学报(医学版),2011,30(1):22-23,50.
［36］范国鑫,冯赞杰,彭慈军,等.杜仲皮水提取物及醇提取物预灌胃大鼠肝脏缺血再灌注处理后肝损伤情况观察［J］.山东医药,2021,61(15):21-25.
［37］张桂霞,宋昕,郭六雷,等.全杜仲胶囊治疗新发轻度高血压的临床效果［J］.临床合理用药杂志,2022,15(16):54-56.
［38］徐国兵.一种治疗糖尿病伴高血脂症的药物组合物及其制备方法:CN103006725A［P］.2013-04-03.
［39］王鹏,孙齐明.全杜仲胶囊治疗骨质疏松性下肢骨折术后60例临床观察［J］.辽宁中医杂志,2022,49(4):135-137.
［40］朱换平,赵继荣,石敏,等.杜仲腰痛丸治疗老年骨质疏松性腰背痛患者的临床观察［J］.中药药理与临床,2021,37(6):153-156.
［41］刘育婷,滕薇,袁成代,等.三种炮制方法对不同产地杜仲的药效成分影响因素分析［J］.现代中医药,2020,40(5):18-21.
［42］张萍,李明华,周娟,等.杜仲炮制工艺对其质量的影响及化学成分与药理研究进展［J］.中国药学杂志,2020,55(6):421-427.
Memo
基金项目：陕西省科技厅一般项目-青年项目（2023-JC-QN-0821）；陕西省教育厅一般专项项目（22JK0348）；大学生创新创业训练计划项目（S202210716003）；陕西中医药大学附属医院院级项目(2020MS019)